Abiopharma

🔍 LIPPS RANDALL A (Executive)

Company: OMNICELL, INC. (OMCL)

Report Date: 2026-04-01

Detailed Transactions and Holdings:

• Acquired 90,939 shares of Common Stock (Direct)
  Date: 2026-04-01 | Code: A | equity_swap_involved: 0 | shares_owned_after: 535,531.07 | transaction_form_type: 4 | Footnotes: F3
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-04-01 | Code: H | nature_of_ownership: In Trust with Wife | shares_owned_after: 355,861.00 | Footnotes: F1
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-04-01 | Code: H | nature_of_ownership: In Trust for Children | shares_owned_after: 8,051.00 | Footnotes: F2

Footnotes:

• F1: Shares held in trust with Mr. Lipps' wife.
• F2: Shares held in trust for the benefit of Mr. Lipps' children.
• F3: Represents Restricted Stock Units ("RSUs") granted in connection with the Issuer's equity incentive plan. One-third of the RSUs subject to the grant will vest on the first anniversary of the grant date; the remaining two-thirds of the RSUs subject to the grant will vest in equal installments on each of the second and third anniversary of the grant date.